PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1304718.43%
10Y revenue/share CAGR under 50% of SMR.AX's 9339710.28%. Michael Burry would suspect a lasting competitive disadvantage.
307.22%
5Y CAGR of 307.22% while SMR.AX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
68.52%
3Y CAGR of 68.52% while SMR.AX is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
48.56%
OCF/share CAGR of 48.56% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-183.46%
Negative 5Y OCF/share CAGR while SMR.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-545.17%
Negative 3Y OCF/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
35.69%
Positive 10Y CAGR while SMR.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
88.08%
Net income/share CAGR of 88.08% while SMR.AX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-70.46%
Negative 3Y CAGR while SMR.AX is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
88.98%
Equity/share CAGR of 88.98% while SMR.AX is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-3408.92%
Negative 3Y equity/share growth while SMR.AX is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.